Sphere Bio launches Cyto-Mine® Chroma and announces Early Access Program News Sphere Bio launches Cyto-Mine® Chroma and announces Early Access Program
Cyto-Cellect® Fc Fusion Assay Kit launched to expedite cell line development for fusion proteins News Cyto-Cellect® Fc Fusion Assay Kit launched to expedite cell line development for fusion proteins
Sphere Bio strengthens global commercial teams and establishes direct sales and support channel in North America News Sphere Bio strengthens global commercial teams and establishes direct sales and support channel in North America
Cyto-Mine® Chroma announced to accelerate and streamline workflows News Cyto-Mine® Chroma announced to accelerate and streamline workflows
Dr. Alex Dickinson appointed as Non-Executive Director News Dr. Alex Dickinson appointed as Non-Executive Director
Sphere Bio awarded gold accreditation by Investors in People News Sphere Bio awarded gold accreditation by Investors in People
Sphere Bio Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024 News Sphere Bio Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024
Cyto-Cellect® PLUS launched to accelerate cell line development workflows News Cyto-Cellect® PLUS launched to accelerate cell line development workflows
Curtis Nicholson appointed as Director of Sales, EMEA, to support accelerated growth in key markets News Curtis Nicholson appointed as Director of Sales, EMEA, to support accelerated growth in key markets
Dale Levitzke appointed as Chief Executive Officer News Dale Levitzke appointed as Chief Executive Officer
